KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Depreciation & Amortization (CF) (2016 - 2025)

Medpace Holdings' Depreciation & Amortization (CF) history spans 11 years, with the latest figure at $6.9 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 3.4% year-over-year to $6.9 million; the TTM value through Dec 2025 reached $27.2 million, down 2.24%, while the annual FY2025 figure was $27.2 million, 2.24% down from the prior year.
  • Depreciation & Amortization (CF) reached $6.9 million in Q4 2025 per MEDP's latest filing, up from $6.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $7.2 million in Q3 2024 to a low of $3.8 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $5.7 million, with a median of $6.1 million recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 55.4% in 2021, then decreased 4.82% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $4.2 million in 2021, then grew by 21.31% to $5.1 million in 2022, then increased by 26.62% to $6.4 million in 2023, then rose by 11.13% to $7.1 million in 2024, then decreased by 3.4% to $6.9 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Depreciation & Amortization (CF) are $6.9 million (Q4 2025), $6.8 million (Q3 2025), and $6.8 million (Q2 2025).